Crestline Management LP Sells 33,815 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Crestline Management LP decreased its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 25.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 100,649 shares of the company’s stock after selling 33,815 shares during the quarter. Crestline Management LP owned […]

Related Keywords

Stifel Nicolaus ,Quarter For Syndax Pharmaceuticals ,Jpmorgan Chase Co ,Syndax Pharmaceuticals Profile ,Syndax Pharmaceuticals Inc ,Citigroup ,Meadowbrook Investment Advisors ,Nasdaq ,Securities Exchange Commission ,Syndax Pharmaceuticals Stock Down ,News Ratings For Syndax Pharmaceuticals Daily ,Syndax Pharmaceuticals ,Annandale Capital ,Quadrant Capital Group ,Crestline Management ,Free Report ,Brook Investment Advisors ,Capital Group ,Pharmaceuticals Stock Down ,Get Free Report ,Syndax Pharmaceuticals Daily ,